Evidence map›Paper›PMID 40261363›Full record

ReviewRadiologie (Heidelberg, Germany)2025

[Therapeutic concepts in treatment of lymphedema].

Christian Dirk Taeger, Claus Christian Pieper, Daniel Schiltz

Abstract readEnglish AbstractReview
In one paragraph

Review in Radiologie (Heidelberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Christian Dirk TaegerPlastische Chirurgie & Ästhetik an der Isar, Widenmayerstraße 16, 80538, München, Deutschland. taeger.christian@gmail.com.
Claus Christian PieperSektion für minimal invasive Lymphgefäßtherapie, Klinik für Diagnostische und Interventionelle Radiologie, Universitätsklinikum Bonn, Venusberg-Campus 1, 53127, Bonn, Deutschland.
Daniel SchiltzKlinik für Plastische und Ästhetische Chirurgie, Handchirurgie, Helios Klinikum Emil von Behring, 14163, Berlin, Deutschland. daniel.schiltz@helios-gesundheit.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLymphoedema is a chronically progressive disease which, if left untreated, can lead to a massive reduction in quality of life and secondary diseases such as recurrent erysipelas. For a long time, purely conservative therapy was considered the only treatment option for primary or secondary chronic lymphedema of the upper or lower extremities. Only in very pronounced late forms were resection procedures such as liposuction or tissue removal considered as further treatment options. A series of modern reconstructive therapy procedures are now available thanks to the-in some cases rapid-further development of diagnostic and microsurgical procedures, which in many cases can significantly alleviate the severity of the disease in the hands of experienced microsurgeons.

aimThe aim of this article is to present the modern treatment options for lymphedema according to the current state of scientific knowledge in a practice-oriented manner and to provide guidelines for the optimal treatment of affected patients.

conclusionIn addition to indispensable conservative therapy, modern microsurgical procedures can lead to successful and lasting symptom relief in mandy cases and should be considered at an early stage. Preoperative diagnostics are essential for choosing the right treatment and its success.

Indexed as

LymphedemaMicrosurgeryPlastic Surgery ProceduresHumansLipectomyLymphatic surgeryLymphovenous anastomosisMicrosurgerySupermicrosurgeryVascularized lymph node transfer

Identifiers

PMID40261363
PMCPMC12041117

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.